Roche Ophthalmology Macular Disease XR Simulation
Challenge & Context
Macular disease can take many forms, e.g. age-related macular degeneration (AMD) being one of the most common conditions and the most significant cause of sight loss. The global number of people living with macular disease globally is estimated to reach 288 million by 2040. The condition today impacts nearly 11 million people in the US alone, with the number expected to increase twofold by 2050, with people of all ages living with the condition. Even though no cure currently exists for AMD, treatment may slow down the disease and diminish the severity of vision loss. Therefore, it requires additional awareness. Being a global leader in Pharmaceuticals and Diagnostics, Roche together with Lucid Reality Labs took this challenge through XR technology.
With the primary goal of spreading awareness about macular disease, which can be the most effectively executed while immersing in real-life experience, Roche, together with Lucid Reality Labs decided to achieve this immersiveness using Extended Reality (XR). The solution named “Seeing the Problem” The Extended Reality (XR) Ophthalmology Macular Disease Simulation was developed to address this challenge. It is a brand-new unique product that, for the first time in the history of Ophthalmology, allows healthcare practitioners, medical students and patient associations to experience first-hand and share the pain and challenges of people living with the macular disease condition.
Features & Functions
The product was built using visual materials, medical specialists’ insights, and patient feedback to ensure accurate condition representation. The XR experience was developed using one of the most advanced mixed reality headsets on the market, Varjo XR-3, with the highest visual fidelity. Experience utilized the device’s eye-tracking, making it impossible to avert from the symptoms and see-through capabilities that overlayed the real-life objects and surroundings with the condition symptoms in real-time (visual distortions, increased blurriness of printed words, and well-defined blind spot in their field of vision).
Different Levels of Macular Disease Conditions
Parliamentary drop-in for the UK MPs
Benefits of the Product
The XR solution presented in the UK House of Parliament was highly praised by more than 50 Members of Parliament as they could experience the macular disease conditions, feel and engage in the daily routine of a person suffering from this condition and empower further steps to improve care for such patients.
Results & Impact
Beyond that, the presented XR solution paves the way for technology into some currently neglected or underfunded social problems, which can be addressed by using immersive technology and changing the quality of lives of millions worldwide.